Tìm kiếm
Sanofi SA
SNYThêm vào danh sách theo dõi
43.155USD
-1.085-2.45%
Đóng cửa 09-08 16:00（ET）
103.47BVốn hóa
12.01P/E TTM
Thêm thông tin về Sanofi SA Công ty
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Sanofi SA Hồ sơ
Mã chứng khoánSNY
Tên công tySanofi SA
Ngày IPOJul 01, 2002
Giám đốc điều hànhHudson (Paul)
Số lượng nhân viên84587
Loại chứng khoánDepository Receipt
Kết thúc năm tài chínhJul 01
Địa chỉ46 Avenue de la Grande Armee
Thành phốPARIS
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaFrance
Mã bưu điện75017
Điện thoại33153774000
Trang webhttps://www.sanofi.com/
Mã chứng khoánSNY
Ngày IPOJul 01, 2002
Giám đốc điều hànhHudson (Paul)
Lãnh đạo công ty của Sanofi SA
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Ms. Rachel Duan
Ms. Rachel Duan
Independent Director
Independent Director
--
--
Ms. Lise Kingo
Ms. Lise Kingo
Independent Director
Independent Director
--
--
Ms. Natalie Bickford
Ms. Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Chief People Officer, Executive Vice President, Member of the Executive Committee
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Sanofi SA?
Năm cổ đông hàng đầu của Sanofi SA là: Mr. Olivier Charmeil
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Sanofi SA (SNY)?
Tính đến ngày 2026Q1, có 1330 tổ chức nắm giữ cổ phiếu của Sanofi SA, với tổng giá trị thị trường khoảng 225.52M, chiếm 9.34% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -36323619.00.